Intelligent pill cap monitors patient compliance; India says WHO confuses counterfeit and patent issues;

> India and Thailand have called for an end to the World Health Organization's involvement in the International Medical Products Anti-Counterfeiting Taskforce, saying WHO is confusing counterfeit issues with patent protection. Article

> Vitality GlowCap, an intelligent pill bottle cap that uses light, sound and a cellular network to help track patient adherence to drug regimen, has won the innovation category in the Compliance Package of the Year awards. Release

> Contract manufacturer DPT Labs has completed a $15 million expansion of its 450,000-square-foot Center of Excellence for Semi-solids & Liquids in San Antonio. Article

> Wyeth is suing Quality King Distributors, claiming the distributor tallied $1.3 million in payments from the drugmaker based on phony returns in a 2007 recall of Robitussin and Dimetapp medications. Item

> White particles in some vials of the anti-inflammatory Dyloject have prompted the recall of all batches in the U.K. by Therabel, a licensee of Javelin Pharmaceuticals. Release

Suggested Articles

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.

It took four tries over four years, but Perrigo has finally gotten FDA approval of its generic of Teva’s tricky-to-make ProAir HFA asthma inhaler.